Auflistung Nach Schlagwort "tranexamic acid"
Anzeige der Dokumente 1-7 von 7
-
Antithrombotic therapy for elderly patients with acute coronary syndrome: Reasons to be cautious
(2020)[No abstract available] -
Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11–13 November 2018
(2019)The purpose of the European Stroke Organisation–Karolinska Stroke Update Conference is to provide updates on recent stroke therapy research and to give an opportunity for the participants to discuss how these results may ... -
Deciphering the genetics of primary angioedema with normal levels of C1 inhibitor
(2020)The genetic alteration underlying the great majority of primary angioedema with normal C1 inhibitor (nl-C1-INH-HAE) cases remains unknown. To search for variants associated with nl-C1-INH-HAE, we genotyped 133 unrelated ... -
Efficacy of local administration of tranexamic acid for blood salvage in patients undergoing intertrochanteric fracture surgery
(2016)Objectives: The primary aim of this study was to assess whether local administration of tranexamic acid (TXA) reduced the need for a blood transfusion in elderly patients treated with an intramedullary (IM) nail for an ... -
The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency
(2021)Hereditary angioedema (HAE) is a rare condition, mostly due to genetic deficiency of complement C1 inhibitor (C1-INH). The rarity of HAE impedes extensive data collection and assessment of the impact of certain factors ... -
Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment
(2017)A new form of hereditary angioedema (HAE) was identified in the year 2000. Its clinical appearance resembles HAE types I and II, which are caused by mutations that result in a deficiency of C1 inhibitor (C1-INH). In patients ... -
Plasminogen glycoforms alteration and activation susceptibility associated with the missense variant p.Lys330Glu in HAE-PLG patients
(2020)[No abstract available]